Cogent Biosciences, Inc. (COGT)
38.89
+0.04
(+0.10%)
USD |
NASDAQ |
Mar 02, 16:00
38.16
-0.73
(-1.88%)
After-Hours: 06:32
Cogent Biosciences Total Liabilities (Quarterly) : 301.24M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 84.20B |
| Sarepta Therapeutics, Inc. | 2.209B |
| BridgeBio Pharma, Inc. | 3.013B |
| Olema Pharmaceuticals, Inc. | 44.96M |
| Revolution Medicines, Inc. | 777.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 937.61M |
| Shareholders Equity (Quarterly) | 636.37M |
| Debt to Equity Ratio | 0.3752 |
| Current Ratio | 14.23 |
| Net Debt Paydown Yield | -0.77% |